These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 18992700)
21. [Significant improvement of motor symptoms by deep brain stimulation of bilateral subthalamic nucleus in patients with moderate or advanced Parkinson's disease]. Chen J; Liu JL; Chen X; Qian H; Xian WB; Zhou HY; Liu YM; Ye XF; Zheng YF; Zhang SL; Chen L; Li JR; Liu ZL; Pei Z Zhonghua Yi Xue Za Zhi; 2011 Feb; 91(5):291-5. PubMed ID: 21419000 [TBL] [Abstract][Full Text] [Related]
22. Comparison of unilateral pallidotomy and subthalamotomy findings in advanced idiopathic Parkinson's disease. Coban A; Hanagasi HA; Karamursel S; Barlas O Br J Neurosurg; 2009 Feb; 23(1):23-9. PubMed ID: 19234905 [TBL] [Abstract][Full Text] [Related]
23. Double-blind, placebo-controlled study of entacapone in levodopa-treated patients with stable Parkinson disease. Olanow CW; Kieburtz K; Stern M; Watts R; Langston JW; Guarnieri M; Hubble J; Arch Neurol; 2004 Oct; 61(10):1563-8. PubMed ID: 15477510 [TBL] [Abstract][Full Text] [Related]
24. A randomized placebo-controlled trial of rasagiline in levodopa-treated patients with Parkinson disease and motor fluctuations: the PRESTO study. Parkinson Study Group Arch Neurol; 2005 Feb; 62(2):241-8. PubMed ID: 15710852 [TBL] [Abstract][Full Text] [Related]
25. Cognitive and motor effects of dopaminergic medication withdrawal in Parkinson's disease. Fern-Pollak L; Whone AL; Brooks DJ; Mehta MA Neuropsychologia; 2004; 42(14):1917-26. PubMed ID: 15381022 [TBL] [Abstract][Full Text] [Related]
26. Prevalence, determinants, and effect on quality of life of freezing of gait in Parkinson disease. Perez-Lloret S; Negre-Pages L; Damier P; Delval A; Derkinderen P; Destée A; Meissner WG; Schelosky L; Tison F; Rascol O JAMA Neurol; 2014 Jul; 71(7):884-90. PubMed ID: 24839938 [TBL] [Abstract][Full Text] [Related]
27. Concurrent administration of donepezil HCl and levodopa/carbidopa in patients with Parkinson's disease: assessment of pharmacokinetic changes and safety following multiple oral doses. Okereke CS; Kirby L; Kumar D; Cullen EI; Pratt RD; Hahne WA Br J Clin Pharmacol; 2004 Nov; 58 Suppl 1(Suppl 1):41-9. PubMed ID: 15496222 [TBL] [Abstract][Full Text] [Related]
28. Apathy and depression in Parkinson's disease: the Belgrade PD study report. Ziropadja Lj; Stefanova E; Petrovic M; Stojkovic T; Kostic VS Parkinsonism Relat Disord; 2012 May; 18(4):339-42. PubMed ID: 22166396 [TBL] [Abstract][Full Text] [Related]
29. Startling facts about emotion in Parkinson's disease: blunted reactivity to aversive stimuli. Bowers D; Miller K; Mikos A; Kirsch-Darrow L; Springer U; Fernandez H; Foote K; Okun M Brain; 2006 Dec; 129(Pt 12):3356-65. PubMed ID: 17095520 [TBL] [Abstract][Full Text] [Related]
30. Adding a dopamine agonist to preexisting levodopa therapy vs. levodopa therapy alone in advanced Parkinson's disease: a meta analysis. Talati R; Baker WL; Patel AA; Reinhart K; Coleman CI Int J Clin Pract; 2009 Apr; 63(4):613-23. PubMed ID: 19222614 [TBL] [Abstract][Full Text] [Related]
31. Compulsive use of dopaminergic drug therapy in Parkinson's disease: reward and anti-reward. Evans AH; Lawrence AD; Cresswell SA; Katzenschlager R; Lees AJ Mov Disord; 2010 May; 25(7):867-76. PubMed ID: 20461804 [TBL] [Abstract][Full Text] [Related]
32. Intrastriatal transplantation of microcarrier-bound human retinal pigment epithelial cells versus sham surgery in patients with advanced Parkinson's disease: a double-blind, randomised, controlled trial. Gross RE; Watts RL; Hauser RA; Bakay RA; Reichmann H; von Kummer R; Ondo WG; Reissig E; Eisner W; Steiner-Schulze H; Siedentop H; Fichte K; Hong W; Cornfeldt M; Beebe K; Sandbrink R; Lancet Neurol; 2011 Jun; 10(6):509-19. PubMed ID: 21565557 [TBL] [Abstract][Full Text] [Related]
33. Short- and long-term dopaminergic effects on dysarthria in early Parkinson's disease. Skodda S; Visser W; Schlegel U J Neural Transm (Vienna); 2010 Feb; 117(2):197-205. PubMed ID: 20012657 [TBL] [Abstract][Full Text] [Related]
34. [Depression and dementia: the most frequent non-motor symptoms of Parkinson disease]. Sławek J; Derejko M Neurol Neurochir Pol; 2003; 37 Suppl 5():103-15. PubMed ID: 15098337 [TBL] [Abstract][Full Text] [Related]
35. A multicenter, open-label, sequential study comparing preferences for carbidopa-levodopa orally disintegrating tablets and conventional tablets in subjects with Parkinson's disease. Nausieda PA; Pfeiffer RF; Tagliati M; Kastenholz KV; DeRoche C; Slevin JT Clin Ther; 2005 Jan; 27(1):58-63. PubMed ID: 15763606 [TBL] [Abstract][Full Text] [Related]